Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 18 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

18 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Nov. 10, 2017 GMED S 10b5-1 14,551 $35.00 $509,285 35,217 Direct -29.24% Disposed 116.0% (price as of 2026-10-02)
Nov. 9, 2017 GMED S 10b5-1 51,449 $35.00 $1,800,715 49,768 Direct -50.83% Disposed 116.0% (price as of 2026-10-02)
Sept. 6, 2017 GMED S 15,000 $29.99 $449,850 101,217 Direct -12.91% Disposed 152.1% (price as of 2026-10-02)
Aug. 5, 2016 GMED S 32,992 $23.39 $771,683 116,217 Direct -22.11% Disposed 223.2% (price as of 2026-10-02)
Aug. 4, 2016 GMED S 74,700 $23.36 $1,744,992 116,217 Direct -39.13% Disposed 223.6% (price as of 2026-10-02)
Nov. 16, 2015 GMED S 5,000 $25.80 $129,000 116,217 Direct -4.12% Disposed 193.0% (price as of 2026-10-02)
Jan. 30, 2013 GMED S 10b5-1 31,103 $12.87 $400,296 121,217 Direct -20.42% Disposed 487.4% (price as of 2026-10-02)
Aug. 8, 2012 GMED S 16,910 $11.16 $188,716 152,320 Direct -9.99% Disposed 577.4% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Feb. 2, 2018 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (40,000) $45.64 Feb. 2, 2028 40,000 Acquired
Jan. 30, 2017 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (80,000) $26.27 Jan. 30, 2027 80,000 Acquired
Aug. 5, 2016 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (32,992) $2.93 Nov. 1, 2016 32,992 Disposed
Aug. 4, 2016 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (74,700) $2.93 Nov. 1, 2016 74,700 Disposed
Jan. 25, 2016 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (60,000) $25.52 Jan. 25, 2026 60,000 Acquired
July 7, 2015 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (100,000) $25.65 July 7, 2025 100,000 Acquired
Jan. 20, 2015 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (50,000) $24.10 Jan. 20, 2025 50,000 Acquired
Jan. 23, 2014 GMED Stock Option (Right to Buy Class A Common Stock Class A Common Stock (30,000) $23.95 Jan. 23, 2024 30,000 Acquired
Jan. 24, 2013 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (25,000) $13.04 Jan. 24, 2023 25,000 Acquired
Aug. 29, 2012 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (10,000) $15.34 Aug. 29, 2022 10,000 Acquired
Aug. 8, 2012 GMED Stock Option (Right to Buy Class A Common Stock [F2] Class A Common Stock [F2] (12,307) $10.66 Oct. 27, 2021 12,307 Acquired
Aug. 8, 2012 GMED Stock Option (Right to Buy Class A Common Stock) [F2] Class A Common Stock [F2] (15,384) $11.28 April 20, 2021 15,384 Acquired
Aug. 8, 2012 GMED Stock Option (Right to Buy Class A Common Stock) [F2] Class A Common Stock [F2] (9,230) $11.87 June 16, 2020 9,230 Acquired
Aug. 8, 2012 GMED Stock Option (Right to Buy Class A Common Stock) [F2] Class A Common Stock [F2] (9,230) $4.88 Aug. 6, 2019 9,230 Acquired
Aug. 8, 2012 GMED Class B Common Stock Class A Common Stock (92,307) · · 92,307 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 7 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Aug. 2, 2012 GMED Class A Common Stock 76,923 Direct
Aug. 2, 2012 GMED Class B Common Stock [F1]→ Class A Common Stock · Direct
Aug. 2, 2012 GMED Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (107,692) 107,692 Direct
Aug. 2, 2012 GMED Stock Option (Right to Buy Class C Common Stock) [F3]→ Class C Common Stock [F3] · Direct
Aug. 2, 2012 GMED Stock Option (Right to Buy Class C Common Stock) [F3]→ Class C Common Stock [F3] · Direct
Aug. 2, 2012 GMED Stock Option (Right to Buy Class C Common Stock) [F3]→ Class C Common Stock [F3] · Direct
Aug. 2, 2012 GMED Stock Option (Right to Buy Class C Common Stock) [F3]→ Class C Common Stock [F3] · Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

GMED

EVP
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2017 $374,290 · · $666,149 $250,000 · $22,365 $1,312,804
2016 $364,000 · · $482,003 $325,451 · $22,656 $1,194,110
2015 $333,086 $15,787 · $1,220,624 $376,323 · $22,634 $1,968,454

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.